Ana Oaknin Benzaquen

Statistics

Publications

Citations

630

H-Index

Active since

2014

Affiliations

European Institute of Oncology(Current)

Ana Oaknin Benzaquen is an author at European Institute of Oncology specializing in ovarian cancer chemotherapy, ovarian cancer pharmacotherapy, and gynecology.

Publications per year

2014–2019

Publications

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

Amit M. Oza, David Cibula, Ana Oaknin Benzaquen et al. · The Lancet Oncology · 2014 · 544 citations

Medicine, Gynecology, Oncology +14

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

1–2 of 2